US 9290760
Modified iRNA agents
granted A61PA61P1/16A61P31/12
Quick answer
US patent 9290760 (Modified iRNA agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61P, A61P1/16, A61P31/12, A61P31/14, A61P31/20